Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
32
BEAM
Beam Therapeutics
Last Price:
26.02
Seasonality Move:
33.43%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight selling pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.83 | Buy |
20-day SMA: | 25.22 | Buy |
50-day SMA: | 26.27 | Sell |
200-day SMA: | 27.35 | Sell |
8-day EMA: | 25.17 | Buy |
20-day EMA: | 25.17 | Buy |
50-day EMA: | 25.51 | Buy |
200-day EMA: | 26.94 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 51.31 | Buy |
Chaikin Money Flow: | -369164 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.91 - 26.21) | Buy |
Bollinger Bands (100): | (22.63 - 27.29) | Buy |
Beam Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 25.51 while BEAM 8-day simple moving average is 24.83, which is a Buy signal.
- The stock price of BEAM is 25.51 while Beam Therapeutics 20-day SMA is 25.22, which makes it a Buy.
- Beam Therapeutics 50-day simple moving average is 26.27 while BEAM share price is 25.51, making it a Sell technically.
- BEAM stock price is 25.51 and Beam Therapeutics 200-day simple moving average is 27.35, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Sell
The current Beam Therapeutics [BEAM] share price is $25.51. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.1B
Price in USD:
25.51
Share Volume:
784.85K
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
16.95
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 25.51 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 25.51 while BEAM 8-day exponential moving average is 25.17, which is a Buy signal.
- The stock price of BEAM is 25.51 while Beam Therapeutics 20-day EMA is 25.17, which makes it a Buy.
- Beam Therapeutics 50-day exponential moving average is 25.51 while BEAM share price is 25.51, making it a Buy technically.
- BEAM stock price is 25.51 and Beam Therapeutics 200-day simple moving average is 26.94, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Beam Therapeutics is a Sell
- Beam Therapeutics Relative Strength Index (RSI) is 51.31, which suggest Beam Therapeutics is overbought
- The Bollinger Bands (25) for Beam Therapeutics is (23.91 - 26.21), which suggest Beam Therapeutics is a Buy
- The Bollinger Bands (100) for Beam Therapeutics is (22.63 - 27.29), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.